ArticleScientific reports2025
TdT/Cas12a-based biosensor for sensitive detection of DNA breakpoints in sperm cryopreservation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
With the advancement of assisted reproductive technology (ART), sperm cryopreservation has become an essential technique in both clinical and research applications. However, maintaining DNA integrity during the freezing and thawing process remains a significant challenge. This study introduces an innovative TdT/Cas12a-based biosensor to enable precise detection and quantification of sperm DNA breakages. Compared to traditional methods such as the sperm chromatin structure assay (SCSA), this biosensor exhibits exceptional sensitivity (capable of detecting DNA breakages at as low as 0.001 nM) and molecular-level resolution, allowing for the precise localization and quantification of DNA breakpoints. By integrating TdT for nucleotide labeling and Cas12a for signal amplification, the system achieves high specificity and reliability. Additionally, the introduction of a standard strand as a quality control significantly enhances reproducibility. Furthermore, the study explores the protective effects of natural antioxidants on sperm DNA integrity during the freeze-thaw process. The results reveal a marked increase in DNA breakpoints caused by cryopreservation, with the TdT/Cas12a system outperforming traditional methods in providing detailed and accurate assessments. Notably, the addition of antioxidants effectively mitigates DNA damage during the freeze-thaw process, safeguarding sperm DNA integrity. This platform not only represents a significant advancement in DNA damage detection and monitoring but also supports the optimization of cryopreservation protocols and contributes to improving the success and safety of ART. It offers valuable insights and innovative tools for the field of reproductive medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.